Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2013; 19(39): 6548-6554
Published online Oct 21, 2013. doi: 10.3748/wjg.v19.i39.6548
Published online Oct 21, 2013. doi: 10.3748/wjg.v19.i39.6548
Author | Cases (n) | Hypertrophy (range) | Days of interval (range) | Morbidity | Mortality |
Schnitzbauer et al[7] | 25 | 74% (21-192) | 8 (4-8) | 64% | 12% |
Conrad et al[11] | 1 | 44.80% | 9 | 0% | 0% |
Robles Campos et al[12] | 1 | 57% | 7 | 0% | 0% |
Dokmak et al[15] | 8 | 70% (5-147) | 7 | 87.50% | 25% |
Donati et al[16] | 8 | 80% (66-200) | 10 (7-21) | - | - |
Knoefel et al[17] | 7 | 63% | 6 (4-8) | 57.20% | 14.20% |
Machado et al[26] | 8 | 88%1 | 9 | 0% | 0% |
Machado et al[27] | 1 | 159% | 21 | 0% | 0% |
Hahn et al[37] | 1 | 94% | 9 | 0 | 0 |
Sala et al[49] | 10 | 82% (31-140) | 7 | 40% | 0% |
Andriani[50] | 2 | - | 30 | 0% | 0% |
Torres et al[51] | 1 | - | - | - | |
Li et al[52] | 9 | 87.20% | 13 | 22.20% | 22.20% |
- Citation: Donati M, Stavrou GA, Oldhafer KJ. Current position of ALPPS in the surgical landscape of CRLM treatment proposals. World J Gastroenterol 2013; 19(39): 6548-6554
- URL: https://www.wjgnet.com/1007-9327/full/v19/i39/6548.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i39.6548